1
|
Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2.
|
Vaccine
|
2003
|
2.00
|
2
|
Development and biological evaluation of acyl protein thioesterase 1 (APT1) inhibitors.
|
Angew Chem Int Ed Engl
|
2005
|
0.85
|
3
|
Tumor-cell-targeted methionine-enkephalin analogues containing unnatural amino acids: design, synthesis, and in vitro antitumor activity.
|
J Med Chem
|
2006
|
0.85
|
4
|
Fluorescently labeled macrolides as a tool for monitoring cellular and tissue distribution of azithromycin.
|
Pharmacol Res
|
2012
|
0.83
|
5
|
Solid-phase synthesis of lipidated peptides.
|
Chemistry
|
2005
|
0.81
|
6
|
N'-substituted-2'-O,3'-N-carbonimidoyl bridged macrolides: novel anti-inflammatory macrolides without antimicrobial activity.
|
J Med Chem
|
2012
|
0.80
|
7
|
Novel 9a-carbamoyl- and 9a-thiocarbamoyl-3-decladinosyl-6-hydroxy and 6-methoxy derivatives of 15-membered macrolides.
|
Bioorg Med Chem
|
2007
|
0.76
|
8
|
Could LogP be a principal determinant of biological activity in 18-crown-6 ethers? Synthesis of biologically active adamantane-substituted diaza-crowns.
|
Eur J Med Chem
|
2011
|
0.76
|
9
|
Modeling cellular pharmacokinetics of 14- and 15-membered macrolides with physicochemical properties.
|
J Med Chem
|
2011
|
0.76
|
10
|
Synthesis and properties of macrolones characterized by two ether bonds in the linker.
|
Bioorg Med Chem
|
2010
|
0.76
|
11
|
Novel desosamine-modified 14- and 15-membered macrolides without antibacterial activity.
|
Bioorg Med Chem Lett
|
2012
|
0.76
|
12
|
Novel 9a,11-bridged azalides: One-pot synthesis of N'-substituted 2-imino-1,3-oxazolidines condensed to an azalide aglycone.
|
Bioorg Med Chem
|
2010
|
0.75
|
13
|
The design of novel classes of macrolides for neutrophil-dominated inflammatory diseases.
|
Future Med Chem
|
2014
|
0.75
|
14
|
Synthesis of novel adamantyl and homoadamantyl-substituted β-hydroxybutyric acids.
|
Mol Divers
|
2013
|
0.75
|
15
|
Impact of stereochemistry on the biological activity of novel oleandomycin derivatives.
|
Bioorg Med Chem
|
2012
|
0.75
|